Industry News - Ophthalmology Times
Ophthalmology Times
Industry News

Pieris, Allergan collaborate to develop treatments

October 2, 2009

Pieris AG and Allergan will collaborate in the development of agents to treat serious ocular disorders, Pieris has announced.

Bausch & Lomb subsidiaries, CROMA to co-promote bromfenac in Europe

October 2, 2009

Several subsidiaries of Bausch & Lomb have been granted rights from CROMA Pharma GmbH to co-promote and sell bromfenac ophthalmic solution in Europe when it becomes available to that market, announced Bausch & Lomb.

FDA clears Topcon digital fundus camera

October 2, 2009

The FDA has granted 510(k) clearance to a new digital fundus camera (TRC-NW7SF Mark II, Topcon Medical Systems), according to its manufacturer.

I-Therapeutix changes name to Ocular Therapeutix

October 2, 2009

I-Therapeutix has changed its name to Ocular Therapeutix.

AMO launches online ordering service

October 2, 2009

Abbott Medical Optics (AMO) has launched a new online ordering service (AMOeasy, www.amoeasy.com) whereby customers can order the company?s implants and other cataract-related products as well as track orders at any time of day.

Dr. Travis Meredith is new AUPO president

September 16, 2009

Travis Meredith, MD, has been elected as the new president of the Association of University Professors of Ophthalmology (AUPO), which is composed of department chairmen, residency directors, and research directors of ophthalmology departments in the United States and Canada, according to a prepared statement.

Alcon to acquire ESBATech

September 16, 2009

Alcon has announced in a prepared statement that it has entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company.

Bausch & Lomb to consolidate its contact lens manufacturing

September 16, 2009

Bausch & Lomb intends to consolidate its worldwide contact lens manufacturing and proposes to begin moving most of its global contact lens production to its existing sites in Waterford, Ireland, and Rochester, NY, according to a prepared statement. ??

Abbott expected to acquire Visiogen

September 16, 2009

Abbott has announced a definitive agreement to acquire Visiogen Inc. for $400 million in cash, providing the company with a next-generation accommodating IOL technology (Synchrony), according to a prepared statement.

ADVERTISEMENT

Practice ToolsPractice Tools
Coding Counselor
Coding Counselor

Simple and accurate ICD-9 code search. Start Here

Formulary Counselor
Formulary Counselor

Find health plan drug coverage in your area. Start Here

Patient Education
Patient Education

Print customized patient education handouts. Start Here

Surgical Video Center
Surgical Video Center

On-demand surgery demos and presentations. Start Here



Click here